Skip to main content

Andrew Berchuck, MD

Andrew Berchuck, MD
James M. Ingram Professor of Gynecologic Oncology
Campus Mail: 25171 Morris Bldg, Durham, NC 27710
Phone: (919) 684-3765
Email: berch001@mc.duke.edu

Dr. Andrew Berchuck is Director of the Duke Division of Gynecologic Oncology and holds the James M. Ingram Distinguished Professorship. He is a practicing oncologist who is actively involved in the surgical and chemotherapy management of women with ovarian, endometrial and lower genital tract cancers. This includes minimally invasive laparoscopic surgical approaches. He also has developed a research program that focuses on the molecular-genetic alterations involved in malignant transformation of the ovarian and endometrial epithelium. He has published over 300 peer-reviewed papers in these areas. The objectives of his research include 1) identification of ovarian cancer susceptibility polymorphisms through a population-based case-control molecular epidemiologic study, and 2) use of genomic approaches  to elucidate the molecular heterogenetity of ovarian cancer. Thirty fellows and residents have worked in his lab, several of whom are now funded investigators. His research efforts have been recognized nationally and he has received awards for best oral presentation at the annual meetings of both the Society of Gynecologic Oncology and the International Gynecologic Cancer Society. Dr. Berchuck was awarded the Barbara Thomason Ovarian Cancer Research Professorship by the American Cancer Society in 2006. He has served as editor of several books in the field including Principles and Practice of Gynecologic Oncology. Dr. Berchuck also has a major commitment to national activities, and was President of the Society of Gynecologic Oncology in 2008. He served as chair of the scientific advisory committee of the Ovarian Cancer Research Fund (http://www.ocrf.org) in New York City. Finally, he is also head of the steering committee of the international Ovarian Cancer Association Consortium (OCAC), a group of 50 case-control studies that are working together to identify ovarian cancer susceptibility polymorphisms (www.srl.cam.ac.uk/consortia/ocac/index.html).

Education and Training

  • M.D., Case Western Reserve University, 1980

Research

Dr Berchuck is interested in the molecular pathogenesis of ovarian and endometrial cancer. 

View Publications

Publications

Bast, RC, Boyer, CM, Jacobs, I, Xu, FJ, Wu, S, Wiener, J, Kohler, M, and Berchuck, A. "Cell growth regulation in epithelial ovarian cancer." Cancer 71, no. 4 Suppl (February 15, 1993): 1597-1601. (Review)

Scholars@Duke

BAST, RC, BOYER, CM, JACOBS, I, XU, FJ, WU, S, WIENER, J, KOHLER, M, and BERCHUCK, A. "CELL-GROWTH REGULATION IN EPITHELIAL OVARIAN-CANCER." February 15, 1993.

Full Text

Xu, F, Lupu, R, Rodriguez, GC, Whitaker, RS, Boente, MP, Berchuck, A, Yu, Y, DeSombre, KA, Boyer, CM, and Bast, RC. "Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185." Int J Cancer 53, no. 3 (February 1, 1993): 401-408.

Scholars@Duke

Berchuck, A, Kohler, MF, Boente, MP, Rodriguez, GC, Whitaker, RS, and Bast, RC. "Growth regulation and transformation of ovarian epithelium." Cancer 71, no. 2 Suppl (January 15, 1993): 545-551. (Review)

Scholars@Duke

BERCHUCK, A, KOHLER, MF, BOENTE, MP, RODRIGUEZ, GC, WHITAKER, RS, and BAST, RC. "GROWTH-REGULATION AND TRANSFORMATION OF OVARIAN EPITHELIUM." January 15, 1993.

Scholars@Duke

Jr, RCB, Boyer, CM, Jacobs, I, Xu, FJ, Wu, S, Wiener, J, Kohler, M, and Berchuck, A. "Cell growth regulation in epithelial ovarian cancer." Cancer 71, no. 4 SUPPL. (1993): 1597-1601.

Scholars@Duke

Berchuck, A, Kohler, MF, Boente, MP, Rodriguez, GC, Whitaker, RS, and Jr, RCB. "Growth regulation and transformation of ovarian epithelium." Cancer 71, no. 2 SUPPL. (1993): 545-551.

Scholars@Duke

Kohler, MF, Kerns, B-JM, Humphrey, PA, Marks, JR, Jr, RCB, and Berchuck, A. "Mutation and overexpression of p53 in early-stage epithelial ovarian cancer." Obstetrics and Gynecology 81, no. 5 I (1993): 643-650.

Scholars@Duke

WOOLAS, R, XU, FJ, DALY, L, SOPER, JT, BERCHUCK, A, RODRIGUEZ, G, CLARKEPEARSON, DL, BOYER, CM, and BAST, RC. "SCREENING STRATEGIES FOR OVARIAN-CANCER." DIAGNOSTIC ONCOLOGY 3, no. 6 (1993): 287-293.

Scholars@Duke

Rodriguez, GC, Boente, MP, Berchuck, A, Whitaker, RS, O'Briant, KC, Xu, F, and Jr, RCB. "The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines." American Journal of Obstetrics and Gynecology 168, no. 1 I (1993): 228-232.

Scholars@Duke

Pages